These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

467 related items for PubMed ID: 9302931

  • 1. A comparison of the effectiveness of malignancy detection in body fluid examination by the cytopathology and hematology laboratories.
    Kendall B, Dunn C, Solanki P.
    Arch Pathol Lab Med; 1997 Sep; 121(9):976-9. PubMed ID: 9302931
    [Abstract] [Full Text] [Related]

  • 2. Use of the Advia 120 hematology analyzer in the differential cytologic analysis of biological fluids (cerebrospinal, peritoneal, pleural, pericardial, synovial, and others).
    Aulesa C, Mainar I, Prieto M, Cobos N, Galimany R.
    Lab Hematol; 2003 Sep; 9(4):214-24. PubMed ID: 14649464
    [Abstract] [Full Text] [Related]

  • 3. The value of multiple fluid specimens in the cytological diagnosis of malignancy.
    Garcia LW, Ducatman BS, Wang HH.
    Mod Pathol; 1994 Aug; 7(6):665-8. PubMed ID: 7991525
    [Abstract] [Full Text] [Related]

  • 4. Cytology of body fluids from different sites: an approach for early diagnosis of malignancy.
    Pradhan SB, Pradhan B, Dali S.
    JNMA J Nepal Med Assoc; 2006 Aug; 45(164):353-6. PubMed ID: 17676071
    [Abstract] [Full Text] [Related]

  • 5. Tissue culture of cells in serous effusions. Evaluation as an adjunct to cytology.
    Singh G, Dekker A, Ladoulis CT.
    Acta Cytol; 1978 Aug; 22(6):487-9. PubMed ID: 282748
    [Abstract] [Full Text] [Related]

  • 6. Detection of malignancy in body fluids: a comparison of the hematology and cytology laboratories.
    Jerz JL, Donohue RE, Mody RR, Schwartz MR, Mody DR, Zieske AW.
    Arch Pathol Lab Med; 2014 May; 138(5):651-7. PubMed ID: 24786122
    [Abstract] [Full Text] [Related]

  • 7. Flow cytometric analysis and cytopathology of body cavity fluids.
    Stonesifer KJ, Xiang JH, Wilkinson EJ, Benson NA, Braylan RC.
    Acta Cytol; 1987 May; 31(2):125-30. PubMed ID: 3469844
    [Abstract] [Full Text] [Related]

  • 8. Detection of the human telomerase RNA component by in situ hybridization in cells from body fluids.
    Nieh S, Chen SF, Fu E, Jan CI, Lee WH.
    Acta Cytol; 2005 May; 49(1):31-7. PubMed ID: 15717752
    [Abstract] [Full Text] [Related]

  • 9. Diagnostic accuracy of the immunocytochemical study of body fluids.
    Li CY, Ziesmer SC, Wong YC, Yam LT.
    Acta Cytol; 1989 May; 33(5):667-73. PubMed ID: 2675517
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the clinic microscopy laboratory with the cytopathology laboratory in the detection of malignant cells in body fluids.
    Ben-Ezra J, Stastny JF, Harris AC, Bork L, Frable WJ.
    Am J Clin Pathol; 1994 Oct; 102(4):439-42. PubMed ID: 7942600
    [Abstract] [Full Text] [Related]

  • 11. Diagnostic value of cytologic specimens obtained from children with cancer.
    Helson L, Krochmal P, Hajdu SI.
    Ann Clin Lab Sci; 1975 Oct; 5(4):294-7. PubMed ID: 169727
    [Abstract] [Full Text] [Related]

  • 12. Correlation between the papanicolaou stain and the Wright-Giemsa stain in body fluids: a quality assurance study.
    Gammon RR, Kharazi M, Brandt JT, Keyhani-Rofagha S.
    Anal Quant Cytol Histol; 2006 Jun; 28(3):171-4. PubMed ID: 16786726
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic value of clot examination for malignant cells in serous effusions.
    Jalal R, Aftab K, Hasan SH, Pervez S.
    Cytopathology; 2009 Aug; 20(4):231-4. PubMed ID: 18627403
    [Abstract] [Full Text] [Related]

  • 14. Examination of body fluids.
    Feldman BF, Ruehl WW.
    Mod Vet Pract; 1984 Apr; 65(4):295-8. PubMed ID: 6738496
    [Abstract] [Full Text] [Related]

  • 15. The cytopathology of mesothelioma.
    Tao LC.
    Acta Cytol; 1979 Apr; 23(3):209-13. PubMed ID: 294056
    [Abstract] [Full Text] [Related]

  • 16. [Evaluation of capability of cell count and detection of tumor cells in cerebrospinal and body fluids by automated hematology analyzer].
    Takemura H, Tabe Y, Ishii K, Kobayashi Y, Kuno Y, Horii T, Miyake K, Miida T, Ohsaka A.
    Rinsho Byori; 2010 Jun; 58(6):559-64. PubMed ID: 20662266
    [Abstract] [Full Text] [Related]

  • 17. Exfoliative cytology of malignant germ cell tumors.
    Hajdu SI, Nolan MA.
    Acta Cytol; 1975 Jun; 19(3):255-60. PubMed ID: 1056679
    [Abstract] [Full Text] [Related]

  • 18. The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions.
    Illei PB, Ladanyi M, Rusch VW, Zakowski MF.
    Cancer; 2003 Feb 25; 99(1):51-6. PubMed ID: 12589646
    [Abstract] [Full Text] [Related]

  • 19. Performance Characteristics of Body Fluid Cytology Analysis of 344 380 Responses From the College of American Pathologists Interlaboratory Comparison Program in Nongynecologic Cytopathology.
    Tabatabai ZL, Nayar R, Souers RJ, Crothers BA, Davey DD.
    Arch Pathol Lab Med; 2018 Jan 25; 142(1):53-58. PubMed ID: 29048220
    [Abstract] [Full Text] [Related]

  • 20. Improving Malignancy Detection Rates in Body Fluids Submitted to the Hematology Laboratory for Nucleated Cell Count and Differential: A Quality Improvement Study.
    Zhang ML, Maglantay RJ, Cunningham VL, Goodwin MT, Feeney MW, Keefe J, Tambouret RH, Sohani AR.
    Arch Pathol Lab Med; 2021 Feb 01; 145(2):201-207. PubMed ID: 33501495
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.